Gapping up
In reaction to strong earnings/guidance: IXYS +19.7%, BIG +12.5%, VEEV +10.5%, ULTA +8.6%, JKS +3.9%, CANF +2.9%, JASO +1%, NQ +0.5%
M&A news: FEIC +12.6% (to be acquired by Thermo Fisher Scientific (TMO) for $107.50/share), VRX +7.8% (WSJ reports VRX rejected a takeover offer by Takeda Pharma (TKPYY) and TPG earlier this year), LC +5.3% (in talks with Citi (C) to either sell or receive financing for future loans, according to the WSJ)
Select metals/mining stocks trading higher: RIO +2%, BHP +1.7%, BBL +1.6%, GFI +1.1%, VALE +0.7%, FCX +0.5%
Other news: RLYP +28.3% (FDA issues to competitive drug maker AZN a CRL for sodium zirconium cyclosilicate), TTNP +25.7% (receives FDA approval for Probuphine for the maintenance treatment of opioid addiction), DNAI +9.4% (licenses cancer drug candidate targeting CDC7 from Carna Biosciences; positioned for clinical trials in 2017), TGTX +9.4% (confirmed Jubilant Biosy and Checkpoint Therapeutics (FBIO unit) collaboration for the treatment of hematological malignancies), VNDA +7% (announces FDA approval of Co's sNDA for Fanapt), HERO +3.1% (announces Transfer of Hercules Highlander and Execution of Restructuring Support Agreement), ETE +2.2% (files Affirmative Defenses and Counterclaim in the lawsuit brought by The Williams Companies (WMB) in the Delaware Court of Chancery)
Analyst comments: VSLR +6.5% (upgraded to Buy from Hold at Deutsche Bank)